Ablation Technology Market by Technology (RF, Pulse Field, Microwave, Laser, Electrical, Ultrasound, Cryo), Product (Generator, Electrode, Probe), Application (CV, Cancer, Pain, Ortho, Cosmetics), Enduser (Hospital, ASC) & Region Global Forecasts to 2029
Market Growth Outlook Summary
The global ablation technology market growth forecasted to transform from USD 6.11 billion in 2024 to USD 9.62 billion by 2029, driven by a CAGR of 9.5%. The drivers for this market include expanding access to healthcare services, an increasing preference for minimally invasive treatments, and the use of ablation procedures in expanded application fields that fuel the ablation technology market growth. Additionally, factors such as a growing number of public campaigns to increase awareness related to early detection, a rise in global healthcare expenditure, and supportive reimbursement policies further contribute to the growth of the ablation technology market. The ablation technology market has experienced a surge on the global level due to lucrative opportunities offered by emerging countries such as India and China. Furthermore, factors such as the expansion of the private healthcare sector and increasing patient population drive the adoption of ablation solutions in the end user facilities.
Ablation Technology Market Trends
To know about the assumptions considered for the study, Request for Free Sample Report
Ablation Technology Market Dynamics
Driver: Emerging ablation technologies
Pulse-field ablation (PFA) is a potentially effective technique for treating cardiac diseases. This non-thermal technique offers a tissue selectivity feature and protects neighboring tissues from harm. PFA for arrhythmias has produced encouraging findings in most preclinical and clinical studies. Additionally, growing R&D expenditure, promoting clinical trials, and recently approved products have increased the market need for this technology. In 2024, Bio Sense Webster, a division of Johnson & Johnson (US), announced that VARIPULSE had received European CE approval for using pulsed-field ablation to treat symptomatic drug-refractory recurrent paroxysmal atrial fibrillation.
Restraint: Rigorous regulatory framework
The US FDA classifies some ablation devices in Class III and the majority in Class II. Class II devices are subjected to control requirements, extended regulatory procedures, and general control requirements. Additional testing, evaluation, and labeling specifications are measures considered in the regulatory framework, which ultimately enhances the time and financial requirements for the product creation and marketing. The phases of the regulatory process can take long waiting periods, particularly concerning Class II devices with notable limitations; this may hamper innovation, and patients might not be promptly presented with potentially life-saving advances.
Opportunity: Growth potential in emerging economies
Increasing healthcare spending in emerging economies such as China, India, Brazil, and Mexico is expected to profitably present the ablation technology market. For example, almost 50% of the world's cancer patients live in emerging economies, as per GLOBOCAN 2020 data. Rising government initiatives to improve payment coverage and healthcare services support the rising use of ablation systems. The market for ablation solutions in emerging economies is anticipated to be further driven by the rise in per capita healthcare expenditure and improved access to healthcare in emerging economies.
Challenge: Therapeutic challenges and hazardous effects of ablation
Market participants have difficulty proving the effectiveness of ablation-based therapies despite their advantages. During treating cardiovascular diseases, catheter ablation may cause weariness, bleeding, infection, and damage to the nearby blood vessels. Thus, doctors may recommend medicine instead of cardiac ablation treatment to minimize adverse effects. Gases such as nitrogen, nitrous oxide, argon, and carbon dioxide are cryogens in cryotherapy systems. These cryogenic gases serve as coolants to reach extremely low temperatures to perform cryotherapy. A loss of consciousness may occur at extremely low cryogenic temperatures. In the years to come, the cryotherapy business may face challenges, and one of the potential reasons for this is expected to be the dangerous effects of cryogenic gases used in several cryosurgery equipment and cryochambers.
Ablation Technology Market Ecosystem
By technology, the radiofrequency ablation segment accounted for the largest market share of the ablation technology industry 2023.
Based on technology, the ablation technology market is segmented into radiofrequency ablation, laser/light ablation, ultrasound ablation, electrical ablation, cryoablation, microwave ablation, pulsed-field ablation, and hydrothermal/hydromechanical ablation. The increasing use of radiofrequency ablation in aesthetic surgeries, proven safety, and long-term efficacy of the technology drives segment growth. Radiofrequency ablation for aesthetic treatments, such as wrinkle reduction and body contouring, also contributes to market growth due to the rising demand for non-surgical treatments globally across all age groups.
By product, the consumables segment accounted for the largest market share of the ablation technology industry in 2023.
Based on product, the ablation technology market is segmented into systems and consumables. In 2023, the consumables segment accounted for the largest market share. A surge in oncological surgeries, the development of multi-electrode catheters, and the rising emphasis on ablation treatment to treat various complications such as atrial fibrillation contribute to the increasing adoption of ablation systems. Consumables are single-use devices and should be replaced for every new patient; this contributes to the recurring revenue of the company and is expected to propel market growth.
By application, the cardiovascular disease treatment segment held the largest market share of the ablation technology industry in 2023.
Based on application, the ablation technology market is segmented into cardiovascular disease treatment, cancer treatment, orthopedic treatment, cosmetic/aesthetic surgery, urological treatment, gynecological segment, pain management, ophthalmology treatment, and other applications. The cardiovascular disease treatment segment held the largest market share in 2023. The cosmetic /aesthetic surgery segment is expected to grow significantly from 2024 to 2029. Factors such as proven improved safety in clinical studies and enhanced health promotion campaigns to raise awareness related to early diagnosis drive segment growth.
By end user, the hospitals, surgical centers, and ablation centers segment commanded the largest market share of the ablation technology industry.
Based on end users, the ablation technology market is segmented into hospitals, surgical centers, and ablation centers; ambulatory surgery centers; medical spas and dermatology & aesthetic clinics. And other end users., The ambulatory surgery centers are expected to grow at the highest CAGR during the study period. The rising prevalence of chronic illness, cost-effectiveness, and the potential benefits of ablation observed in patients with early-stage cancer have contributed to the segment growth.
By region, North America is expected to be the largest market in the global ablation technology industry by 2029.
The US accounted for a significant share of the North American ablation technology market in 2023. The noticeable growth of the regional market is due to its technological leadership, advanced healthcare infrastructure, favorable insurance coverage, increased funding and grants for developing advanced medical equipment, strategic research collaborations, and a supportive market environment fostering innovation. Also, the presence of major players, strategic acquisitions, growing preference for non-surgical solutions, and increasing number of awareness programs further contribute to the market growth.
To know about the assumptions considered for the study, download the pdf brochure
As of 2023, prominent players in the market are Johnson & Johnson (US), Medtronic (US), Boston Scientific Corporation (US), Abbott (US), and Atricure, Inc. (US).
Ablation Technology Market Report Scope
Report Metric |
Details |
Market Revenue in 2024 |
$6.11 billion |
Projected Revenue by 2029 |
$9.62 billion |
Revenue Rate |
Poised to Grow at a CAGR of 10.4% |
Market Driver |
Emerging ablation technologies |
Market Opportunity |
Growth potential in emerging economies |
This report has segmented the global ablation technology market based on technology, product, application, end user, and region.
By Technology
- Radiofrequency ablation
- Laser/Light Ablation
- Ultrasound Ablation
- Electrical Ablation
- Cryoablation
- Microwave Ablation
- Pulsed field Ablation
- Hydrothermal/Hydromechanical Ablation
By Product
- Systems
- Consumables
- Global Ablation Technology Market, By Application
- Cardiovascular Disease Treatment
- Cancer Treatment
- Ophthalmological Treatment
- Pain Management
- Gynecological Treatment
- Urological Treatment
- Orthopedic Treatment
- Cosmetic/ Aesthetic Surgery
- Other Treatments
By Region
-
North America
- US
- Canada
-
Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
-
Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia Pacific
-
Latin America
- Brazil
- Mexico
- Rest of Latin America
Recent Developments of Ablation Technology Market
- In February 2024, Johnson & Johnson (US) received CE mark approval for the VARIPULSE Pulse Field Ablation Platform that helps visualize real-time and enhances workflow.
- In December 2023, Medtronic (US) approved a Pulse Select Pulsed Field Ablation System that helps treat persistent and paroxysmal atrial fibrillation.
Frequently Asked Questions (FAQ):
What is the projected growth rate of the global ablation technology market between 2024 and 2029?
The global ablation technology market is projected to grow from USD 6.11 billion in 2024 to USD 9.62 billion by 2029, demonstrating a robust CAGR of 9.5%.
What are the key factors driving the ablation technology market?
Key factors driving the ablation technology market include expanding access to healthcare services, increasing preference for minimally invasive procedures, and advancements in ablation technologies like Pulse-Field Ablation (PFA).
What are the main challenges facing the ablation technology market?
The ablation technology market faces challenges such as a rigorous regulatory framework, lengthy approval processes for Class II and Class III devices, and potential side effects associated with ablation treatments, including damage to nearby tissues.
Which regions are expected to show significant growth in the ablation technology market?
Emerging economies such as China, India, Brazil, and Mexico are expected to show significant growth in the ablation technology market due to increasing healthcare spending, improved access to healthcare services, and rising awareness of early detection and treatment.
What are the key technologies used in ablation treatments?
Key technologies in ablation treatments include radiofrequency ablation, laser/light ablation, ultrasound ablation, electrical ablation, cryoablation, microwave ablation, pulsed-field ablation, and hydrothermal/hydromechanical ablation.
What are the applications of ablation technology in healthcare?
Ablation technology is used in various healthcare applications, including cardiovascular disease treatment, cancer treatment, orthopedic treatments, aesthetic/cosmetic surgeries, urological treatments, gynecological treatments, and pain management.
What are the recent developments in the ablation technology market?
Recent developments include Johnson & Johnson's CE mark approval for the VARIPULSE Pulse Field Ablation Platform and Medtronic's Pulse Select Pulsed Field Ablation System, which are expected to improve patient outcomes in the treatment of atrial fibrillation.
What role do hospitals and surgical centers play in the ablation technology market?
Hospitals, surgical centers, and ablation centers are the largest end users of ablation technology, providing key infrastructure for treatments, especially for cardiovascular diseases and oncology, with ambulatory surgery centers showing significant growth in the adoption of these technologies.
How are emerging ablation technologies influencing the market?
Emerging ablation technologies such as pulsed-field ablation (PFA) are revolutionizing the market by providing tissue-selective treatments that protect nearby tissues, enhancing patient safety and broadening the scope of ablation procedures.
What are the opportunities for growth in the ablation technology market?
The ablation technology market is expected to witness significant growth in emerging economies due to rising healthcare expenditure, government initiatives to improve healthcare access, and the growing prevalence of cancer and cardiovascular diseases in regions like China, India, and Brazil.
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.
- 5.1 INTRODUCTION
-
5.2 MARKET DYNAMICSDRIVERS- Emerging ablation technologies- Increasing demand for minimally invasive procedures- Growing target patient population- Favorable reimbursement scenario in developed marketsRESTRAINTS- Strong market positioning of alternative therapies- Stringent regulatory systemsOPPORTUNITIES- Growth potential in emerging economiesCHALLENGES- Focus on reuse and reprocessing of devices- Therapeutic challenges and hazardous effects of ablation
-
5.3 VALUE CHAIN ANALYSISRESEARCH & PRODUCT DEVELOPMENTRAW MATERIAL PROCUREMENT AND MANUFACTURINGDISTRIBUTION, MARKETING & SALES, AND POST-SALES SERVICES
-
5.4 SUPPLY CHAIN ANALYSISMANUFACTURERS- Prominent companies- Small and medium-sized enterprisesEND USERS
- 5.5 ECOSYSTEM ANALYSIS
-
5.6 REGULATORY LANDSCAPEREGULATORY ANALYSIS- North America- Europe- Asia Pacific- Latin AmericaREGULATORY APPROVALSKEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS- North America- Europe- Asia Pacific- Latin America- Middle East & Africa
- 5.7 REIMBURSEMENT SCENARIO ANALYSIS
- 5.8 INVESTMENT AND FUNDING SCENARIO
- 5.9 PRICING ANALYSIS
-
5.10 TRADE ANALYSISIMPORT DATA FOR ABLATION PRODUCTS (HS CODE 9018)EXPORT DATA FOR ABLATION PRODUCTS (HS CODE 9018)
-
5.11 PATENT ANALYSISTOP PATENT OWNERS/APPLICANTSLIST OF MAJOR PATENTS
-
5.12 PORTER’S FIVE FORCES ANALYSISTHREAT OF NEW ENTRANTSTHREAT OF SUBSTITUTESBARGAINING POWER OF SUPPLIERSBARGAINING POWER OF BUYERSINTENSITY OF COMPETITIVE RIVALRY
-
5.13 KEY STAKEHOLDERS AND BUYING CRITERIAKEY STAKEHOLDERS IN BUYING PROCESSKEY BUYING CRITERIA
- 5.14 KEY CONFERENCES AND EVENTS, 2024–2025
-
5.15 CASE STUDY ANALYSISRADIOFREQUENCY ABLATION ANALYSIS CASE STUDYTHERMOCOOL CATHETER CASE STUDY
-
5.16 TECHNOLOGY ANALYSISKEY TECHNOLOGIES- Thermal ablation technology- Non-thermal ablation technologyCOMPLEMENTARY TECHNOLOGIES- Medical cooling systemsADJACENT TECHNOLOGIES- Ablation planning software
- 5.17 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
- 5.18 UNMET NEEDS
-
5.19 IMPACT OF AI/GEN AI ON ABLATION TECHNOLOGY MARKETKEY USE CASES
- 6.1 INTRODUCTION
-
6.2 RADIOFREQUENCY ABLATIONLOWER COST AND HIGHER EFFICACY TO PROPEL MARKET GROWTH
-
6.3 LASER/LIGHT ABLATIONLOWER RISK OF TISSUE DAMAGE AND BETTER REAL-TIME MONITORING TO AID MARKET GROWTH
-
6.4 ULTRASOUND ABLATIONHIGH INCIDENCE OF LIVER TUMORS AND CANCER TO FUEL MARKET GROWTH
-
6.5 ELECTRICAL ABLATIONINCREASING NUMBER OF CARDIAC ARRESTS TO BOOST ADOPTION
-
6.6 CRYOABLATIONFEWER COMPLICATIONS AND SHORTER PROCEDURAL TIME TO DRIVE MARKET
-
6.7 MICROWAVE ABLATIONFASTER ABLATION TIME AND LESSER PROCEDURAL PAIN TO AUGMENT MARKET GROWTH
-
6.8 PULSED-FIELD ABLATIONIMPROVED SAFETY, SHORTER PROCEDURAL TIME, AND FEWER COMPLICATIONS TO PROPEL MARKET GROWTH
-
6.9 HYDROTHERMAL/HYDROMECHANICAL ABLATIONINCREASED USAGE IN GYNECOLOGICAL DISORDERS AND MENORRHAGIA TO AID MARKET GROWTH
- 7.1 INTRODUCTION
-
7.2 RADIOFREQUENCY ABLATION SYSTEMSTEMPERATURE-CONTROLLED RADIOFREQUENCY ABLATION SYSTEMS- Technological advancements and improved clinical outcomes to propel segment growthFLUID-COOLED RADIOFREQUENCY ABLATION SYSTEMS- Rising incidence of arrhythmia and growing focus on reducing collateral tissue damage to boost demandROBOTIC CATHETER MANIPULATION SYSTEMS- Manual control of catheter movement and remote navigation to fuel segment
-
7.3 LASER/LIGHT ABLATION SYSTEMSEXCIMER LASER ABLATION SYSTEMS- Low direct tissue interaction, precise ablation zone, and high procedural efficiency to drive adoptionCOLD LASER ABLATION SYSTEMS- Cold laser ablator treatment to release endorphins and support pain management
-
7.4 ULTRASOUND ABLATION SYSTEMSULTRASONIC SURGICAL ABLATION SYSTEMS- Development of user-friendly surgical ablation systems to drive segment growthHIGH-INTENSITY FOCUSED ULTRASOUND ABLATION SYSTEMS- Low procedural time and reduced bleeding to support system adoptionEXTRACORPOREAL SHOCK WAVE LITHOTRIPSY SYSTEMS- Growing incidence of obesity and diabetes to drive segmentMAGNETIC RESONANCE-GUIDED FOCUSED ULTRASOUND ABLATION SYSTEMS- Non-pregnancy safe treatment procedure to limit adoption
-
7.5 ELECTRICAL ABLATION SYSTEMSARGON PLASMA/BEAM COAGULATION SYSTEMS- Increased focus on treating Barrett’s esophagus without dysplasia to augment segment growthIRREVERSIBLE ELECTROPORATION ABLATION SYSTEMS- Selective targeting and better control to aid segment growth
-
7.6 CRYOABLATION SYSTEMSTECHNOLOGICAL ADVANCEMENTS AND INTRODUCTION OF NEW CRYOPROBES TO AID ADOPTIONEPIDERMAL AND SUBCUTANEOUS CRYOABLATION DEVICES
-
7.7 MICROWAVE ABLATION SYSTEMSPRODUCTION OF LARGE ABLATION ZONES WITHOUT HEAT-SINK EFFECT ON SURROUNDING TISSUES TO DRIVE MARKETMICROWAVE THERMOTHERAPY SYSTEMS
-
7.8 HYDROTHERMAL/HYDROMECHANICAL ABLATION SYSTEMSINCREASED NEED FOR MINIMALLY INVASIVE PROCEDURES FOR GYNECOLOGICAL DISORDERS TO SUPPORT MARKET GROWTHENDOMETRIAL HYDROTHERMAL BALLOON ABLATION DEVICES
-
7.9 CONSUMABLESGROWING PREFERENCE FOR ADVANCED MINIMALLY INVASIVE PROCEDURES TO SPUR MARKET GROWTH
- 8.1 INTRODUCTION
-
8.2 CARDIOVASCULAR DISEASE TREATMENTINCREASING TARGET PATIENT POPULATION TO PROPEL MARKET GROWTH
-
8.3 CANCER TREATMENTHIGH PREVALENCE OF CANCER AND NEED FOR ADVANCED TREATMENT PROCEDURES TO AUGMENT MARKET GROWTHLIVER CANCERKIDNEY CANCERPROSTATE CANCERLUNG CANCERBONE METASTASISBREAST CANCER
-
8.4 ORTHOPEDIC TREATMENTGROWING DISEASE PREVALENCE AND RISING GERIATRIC POPULATION TO SPUR MARKET GROWTH
-
8.5 COSMETIC/AESTHETIC SURGERYINCREASING DEMAND FOR AESTHETIC SURGICAL PROCEDURES TO FUEL MARKET GROWTH
-
8.6 UROLOGICAL TREATMENTHIGH DEMAND FOR MINIMALLY INVASIVE PROCEDURES AMONG PATIENTS TO DRIVE MARKET
-
8.7 GYNECOLOGICAL TREATMENTINCREASING REPRODUCTIVE HEALTH CONCERNS AND DECREASING FERTILITY RATE TO PROPEL MARKET GROWTH
-
8.8 PAIN MANAGEMENTMINIMUM RECOVERY TIME AND LONG-LASTING PAIN RELIEF TO SUPPORT MARKET GROWTH
-
8.9 OPHTHALMOLOGICAL TREATMENTRISING PREVALENCE OF VISION DISORDERS AMONG ALL AGE GROUPS TO AID MARKET GROWTH
- 8.10 OTHER APPLICATIONS
- 9.1 INTRODUCTION
-
9.2 HOSPITALS, SURGICAL CENTERS, AND ABLATION CENTERSHIGH ADOPTION OF ROBOTIC PROCEDURES IN SURGERIES AND IMPROVED HEALTHCARE INFRASTRUCTURE TO DRIVE MARKET
-
9.3 AMBULATORY SURGERY CENTERSNEED FOR COST-EFFECTIVE OUTPATIENT TREATMENTS TO SPUR MARKET GROWTH
-
9.4 MEDICAL SPAS AND AESTHETIC & DERMATOLOGY CLINICSINCREASING PREFERENCE FOR MINIMALLY INVASIVE AND NON-INVASIVE AESTHETIC PROCEDURES TO BOOST MARKET GROWTH
- 9.5 OTHER END USERS
- 10.1 INTRODUCTION
-
10.2 NORTH AMERICAMACROECONOMIC OUTLOOK FOR NORTH AMERICAUS- US to dominate North American ablation technology market during forecast periodCANADA- Rising burden of cancer and growing demand for minimally invasive procedures to support market growth
-
10.3 EUROPEMACROECONOMIC OUTLOOK FOR EUROPEGERMANY- Developed healthcare infrastructure and high incidence of chronic diseases to support market growthFRANCE- Growing geriatric population and rising prevalence of cancer to aid market growthUK- Rising target patient population and growing awareness about advanced treatment options to drive marketITALY- Increasing number of clinical trials and growing focus on advanced research activities to augment market growthSPAIN- Increasing government research funding and growing focus on effective cancer diagnosis to propel market growthREST OF EUROPE
-
10.4 ASIA PACIFICMACROECONOMIC OUTLOOK FOR ASIA PACIFICJAPAN- Presence of universal healthcare reimbursement system to augment market growthCHINA- Increased patient pool and favorable government initiatives to fuel market growthINDIA- Modernization of healthcare infrastructure and increased medical tourism to aid market growthAUSTRALIA- Increased research investments and favorable government initiatives to spur market growthSOUTH KOREA- Focus on healthcare R&D and supportive government initiatives to positively impact market growthREST OF ASIA PACIFIC
-
10.5 LATIN AMERICAMACROECONOMIC OUTLOOK FOR LATIN AMERICABRAZIL- Increasing government funding and growing burden of chronic diseases to propel market growthMEXICO- Availability of advanced care initiatives and awareness programs to fuel market growthREST OF LATIN AMERICA
-
10.6 MIDDLE EAST & AFRICAIMPROVED HEALTHCARE INFRASTRUCTURE AND HIGH PUBLIC-PRIVATE INVESTMENTS TO STIMULATE MARKET GROWTHMACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
- 11.1 INTRODUCTION
-
11.2 KEY PLAYER STRATEGY/RIGHT TO WINOVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN ABLATION TECHNOLOGY MARKET
- 11.3 REVENUE ANALYSIS, 2019–2023
- 11.4 MARKET SHARE ANALYSIS, 2023
-
11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023STARSEMERGING LEADERSPERVASIVE PLAYERSPARTICIPANTSCOMPANY FOOTPRINT: KEY PLAYERS, 2023- Company footprint- Technology footprint- Product footprint- Application footprint- End-user footprint- Region footprint
-
11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023PROGRESSIVE COMPANIESRESPONSIVE COMPANIESDYNAMIC COMPANIESSTARTING BLOCKSCOMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
-
11.7 COMPANY VALUATION AND FINANCIAL METRICSFINANCIAL METRICSCOMPANY VALUATION
- 11.8 BRAND/PRODUCT COMPARISON
-
11.9 COMPETITIVE SCENARIOPRODUCT LAUNCHES AND APPROVALSDEALSEXPANSIONS
-
12.1 KEY PLAYERSJOHNSON & JOHNSON- Business overview- Products offered- Recent developments- MnM viewMEDTRONIC- Business overview- Products offered- Recent developments- MnM viewBOSTON SCIENTIFIC CORPORATION- Business overview- Products offered- Recent developments- MnM viewABBOTT- Business overview- Products offered- Recent developmentsATRICURE, INC.- Business overview- Products offered- Recent developmentsANGIODYNAMICS- Business overview- Products offered- Recent developmentsCONMED CORPORATION- Business overview- Products offeredOLYMPUS CORPORATION- Products offered- Recent developmentsVARIAN MEDICAL SYSTEMS, INC.- Business overview- Products offered- Recent developmentsSMITH+NEPHEW- Business overview- Product offered- Recent developmentsSTRYKER- Business overview- Products offered- Recent developmentsCYNOSURE LUTRONIC- Business overview- Products offered- Recent developmentsBIOVENTUS- Business overview- Products offeredMERIT MEDICAL SYSTEMS- Business overview- Products offeredCANYON MEDICAL INC.- Business overview- Products offered
-
12.2 OTHER PLAYERSARTHREX, INC.ICECURE MEDICALMINIMAX MEDICAL HOLDING GROUPCARDIOFOCUSEDAP TMSMERMAID MEDICALMONTERISSONABLATE CORP.ECO MEDICALSURGNOVA
- 13.1 DISCUSSION GUIDE
- 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
- 13.3 CUSTOMIZATION OPTIONS
- 13.4 RELATED REPORTS
- 13.5 AUTHOR DETAILS
- TABLE 1 ABLATION TECHNOLOGY MARKET: INCLUSIONS AND EXCLUSIONS
- TABLE 2 ABLATION TECHNOLOGY MARKET: STUDY ASSUMPTIONS
- TABLE 3 ABLATION TECHNOLOGY MARKET: RISK ASSESSMENT
- TABLE 4 ESTIMATED GERIATRIC POPULATION, BY REGION, 2015 VS. 2030 (IN MILLION)
- TABLE 5 CPT CODES FOR REIMBURSEMENT OF ABLATION TECHNOLOGIES
- TABLE 6 ALTERNATIVE THERAPIES/PROCEDURES FOR ABLATION
- TABLE 7 ABLATION TECHNOLOGY MARKET: ROLE IN ECOSYSTEM
- TABLE 8 US FDA: MEDICAL DEVICE CLASSIFICATION
- TABLE 9 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
- TABLE 10 US: CLASSIFICATION OF ABLATION DEVICES
- TABLE 11 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
- TABLE 12 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PHARMACEUTICAL AND MEDICAL DEVICE AGENCY (PMDA)
- TABLE 13 CHINA: CLASSIFICATION OF MEDICAL DEVICES
- TABLE 14 REGULATORY APPROVALS REQUIRED FOR ABLATION DEVICES, BY COUNTRY
- TABLE 15 NORTH AMERICA: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- TABLE 16 EUROPE: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- TABLE 17 ASIA PACIFIC: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- TABLE 18 LATIN AMERICA: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- TABLE 19 MIDDLE EAST & AFRICA: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- TABLE 20 MEDICAL REIMBURSEMENT CODES FOR CRYOABLATION PROCEDURAL SERVICES IN US (2024)
- TABLE 21 MEDICAL REIMBURSEMENT CODES FOR ABLATION TECHNOLOGY IN US, 2021–2024
- TABLE 22 INDICATIVE SELLING PRICE OF ABLATION SYSTEMS, BY REGION, 2021–2023 (USD)
- TABLE 23 IMPORT DATA FOR ABLATION PRODUCTS (HS CODE 9018), BY COUNTRY, 2019–2023 (USD THOUSAND)
- TABLE 24 EXPORT DATA FOR ABLATION PRODUCTS (HS CODE 9018), BY COUNTRY, 2019–2023 (USD THOUSAND)
- TABLE 25 LIST OF MAJOR PATENTS IN ABLATION TECHNOLOGY MARKET, JANUARY 2022–MARCH 2024
- TABLE 26 ABLATION TECHNOLOGY MARKET: PORTER’S FIVE FORCES
- TABLE 27 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS
- TABLE 28 INFLUENCE OF KEY END USERS ON BUYING PROCESS
- TABLE 29 KEY BUYING CRITERIA FOR END USERS
- TABLE 30 ABLATION TECHNOLOGY MARKET: LIST OF KEY CONFERENCES AND EVENTS, JANUARY 2024–DECEMBER 2025
- TABLE 31 CASE STUDY 1: RADIOFREQUENCY ABLATION ANALYSIS CASE STUDY
- TABLE 32 CASE STUDY 2: THERMOCOOL CATHETER CASE STUDY
- TABLE 33 THERMAL ABLATION TECHNOLOGY: KEY BRAND MAPPING
- TABLE 34 NON-THERMAL ABLATION TECHNOLOGY: KEY BRAND MAPPING
- TABLE 35 ABLATION TECHNOLOGY MARKET: INTENSITY OF CURRENT UNMET NEEDS
- TABLE 36 ABLATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
- TABLE 37 RADIOFREQUENCY ABLATION TECHNOLOGY MARKET, BY REGION, 2022–2029 (USD MILLION)
- TABLE 38 LASER/LIGHT ABLATION TECHNOLOGY MARKET, BY REGION, 2022–2029 (USD MILLION)
- TABLE 39 ULTRASOUND ABLATION TECHNOLOGY MARKET, BY REGION, 2022–2029 (USD MILLION)
- TABLE 40 ELECTRICAL ABLATION TECHNOLOGY MARKET, BY REGION, 2022–2029 (USD MILLION)
- TABLE 41 CRYOABLATION TECHNOLOGY MARKET, BY REGION, 2022–2029 (USD MILLION)
- TABLE 42 MICROWAVE ABLATION TECHNOLOGY MARKET, BY REGION, 2022–2029 (USD MILLION)
- TABLE 43 PULSED-FIELD ABLATION TECHNOLOGY MARKET, BY REGION, 2022–2029 (USD MILLION)
- TABLE 44 HYDROTHERMAL/HYDROMECHANICAL ABLATION TECHNOLOGY MARKET, BY REGION, 2022–2029 (USD MILLION)
- TABLE 45 ABLATION TECHNOLOGY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
- TABLE 46 ABLATION TECHNOLOGY SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 47 RADIOFREQUENCY ABLATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 48 RADIOFREQUENCY ABLATION SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)
- TABLE 49 TEMPERATURE-CONTROLLED RADIOFREQUENCY ABLATION SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)
- TABLE 50 FLUID-COOLED RADIOFREQUENCY ABLATION SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)
- TABLE 51 ROBOTIC CATHETER MANIPULATION SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)
- TABLE 52 LASER/LIGHT ABLATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 53 LASER/LIGHT ABLATION SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)
- TABLE 54 EXCIMER LASER ABLATION SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)
- TABLE 55 COLD LASER ABLATION SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)
- TABLE 56 ULTRASOUND ABLATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 57 ULTRASOUND ABLATION SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)
- TABLE 58 ULTRASONIC SURGICAL ABLATION SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)
- TABLE 59 HIGH-INTENSITY FOCUSED ULTRASOUND ABLATION SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)
- TABLE 60 EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)
- TABLE 61 MAGNETIC RESONANCE-GUIDED FOCUSED ULTRASOUND ABLATION SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)
- TABLE 62 ELECTRICAL ABLATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 63 ELECTRICAL ABLATION SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)
- TABLE 64 ARGON PLASMA/BEAM COAGULATION SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)
- TABLE 65 IRREVERSIBLE ELECTROPORATION ABLATION SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)
- TABLE 66 CRYOABLATION SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)
- TABLE 67 MICROWAVE ABLATION SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)
- TABLE 68 HYDROTHERMAL/HYDROMECHANICAL ABLATION SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)
- TABLE 69 ABLATION TECHNOLOGY CONSUMABLES MARKET, BY REGION, 2022–2029 (USD MILLION)
- TABLE 70 ABLATION TECHNOLOGY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
- TABLE 71 ABLATION TECHNOLOGY MARKET FOR CARDIOVASCULAR DISEASE TREATMENT, BY REGION, 2022–2029 (USD MILLION)
- TABLE 72 ABLATION TECHNOLOGY MARKET FOR CANCER TREATMENT, BY REGION, 2022–2029 (USD MILLION)
- TABLE 73 ABLATION TECHNOLOGY MARKET FOR ORTHOPEDIC TREATMENT, BY REGION, 2022–2029 (USD MILLION)
- TABLE 74 ABLATION TECHNOLOGY MARKET FOR COSMETIC/AESTHETIC SURGERY, BY REGION, 2022–2029 (USD MILLION)
- TABLE 75 ABLATION TECHNOLOGY MARKET FOR UROLOGICAL TREATMENT, BY REGION, 2022–2029 (USD MILLION)
- TABLE 76 ABLATION TECHNOLOGY MARKET FOR GYNECOLOGICAL TREATMENT, BY REGION, 2022–2029 (USD MILLION)
- TABLE 77 ABLATION TECHNOLOGY MARKET FOR PAIN MANAGEMENT, BY REGION, 2022–2029 (USD MILLION)
- TABLE 78 ABLATION TECHNOLOGY MARKET FOR OPHTHALMOLOGICAL TREATMENT, BY REGION, 2022–2029 (USD MILLION)
- TABLE 79 ABLATION TECHNOLOGY MARKET FOR OTHER APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
- TABLE 80 ABLATION TECHNOLOGY MARKET, BY END USER, 2022–2029 (USD MILLION)
- TABLE 81 ABLATION TECHNOLOGY MARKET FOR HOSPITALS, SURGICAL CENTERS, AND ABLATION CENTERS, BY REGION, 2022–2029 (USD MILLION)
- TABLE 82 ABLATION TECHNOLOGY MARKET FOR AMBULATORY SURGERY CENTERS, BY REGION, 2022–2029 (USD MILLION)
- TABLE 83 ABLATION TECHNOLOGY MARKET FOR MEDICAL SPAS AND AESTHETIC & DERMATOLOGY CLINICS, BY REGION, 2022–2029 (USD MILLION)
- TABLE 84 ABLATION TECHNOLOGY MARKET FOR OTHER END USERS, BY REGION, 2022–2029 (USD MILLION)
- TABLE 85 ABLATION TECHNOLOGY MARKET, BY REGION, 2022–2029 (USD MILLION)
- TABLE 86 NORTH AMERICA: ABLATION TECHNOLOGY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 87 NORTH AMERICA: ABLATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
- TABLE 88 NORTH AMERICA: ABLATION TECHNOLOGY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
- TABLE 89 NORTH AMERICA: ABLATION TECHNOLOGY SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 90 NORTH AMERICA: RADIOFREQUENCY ABLATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 91 NORTH AMERICA: LASER/LIGHT ABLATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 92 NORTH AMERICA: ULTRASOUND ABLATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 93 NORTH AMERICA: ELECTRICAL ABLATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 94 NORTH AMERICA: ABLATION TECHNOLOGY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
- TABLE 95 NORTH AMERICA: ABLATION TECHNOLOGY MARKET, BY END USER, 2022–2029 (USD MILLION)
- TABLE 96 NORTH AMERICA: KEY MACROINDICATORS
- TABLE 97 US: ABLATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
- TABLE 98 CANADA: ABLATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
- TABLE 99 EUROPE: ABLATION TECHNOLOGY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 100 EUROPE: ABLATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
- TABLE 101 EUROPE: ABLATION TECHNOLOGY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
- TABLE 102 EUROPE: ABLATION TECHNOLOGY SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 103 EUROPE: RADIOFREQUENCY ABLATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 104 EUROPE: LASER/LIGHT ABLATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 105 EUROPE: ULTRASOUND ABLATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 106 EUROPE: ELECTRICAL ABLATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 107 EUROPE: ABLATION TECHNOLOGY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
- TABLE 108 EUROPE: ABLATION TECHNOLOGY MARKET, BY END USER, 2022–2029 (USD MILLION)
- TABLE 109 EUROPE: KEY MACROINDICATORS
- TABLE 110 GERMANY: ABLATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
- TABLE 111 FRANCE: ABLATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
- TABLE 112 UK: ABLATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
- TABLE 113 ITALY: ABLATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
- TABLE 114 SPAIN: ABLATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
- TABLE 115 REST OF EUROPE: ABLATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
- TABLE 116 ASIA PACIFIC: ABLATION TECHNOLOGY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 117 ASIA PACIFIC: ABLATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
- TABLE 118 ASIA PACIFIC: ABLATION TECHNOLOGY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
- TABLE 119 ASIA PACIFIC: ABLATION TECHNOLOGY SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 120 ASIA PACIFIC: RADIOFREQUENCY ABLATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 121 ASIA PACIFIC: LASER/LIGHT ABLATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 122 ASIA PACIFIC: ULTRASOUND ABLATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 123 ASIA PACIFIC: ELECTRICAL ABLATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 124 ASIA PACIFIC: ABLATION TECHNOLOGY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
- TABLE 125 ASIA PACIFIC: ABLATION TECHNOLOGY MARKET, BY END USER, 2022–2029 (USD MILLION)
- TABLE 126 ASIA PACIFIC: KEY MACROINDICATORS
- TABLE 127 JAPAN: ABLATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
- TABLE 128 CHINA: ABLATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
- TABLE 129 INDIA: ABLATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
- TABLE 130 AUSTRALIA: ABLATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
- TABLE 131 SOUTH KOREA: ABLATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
- TABLE 132 REST OF ASIA PACIFIC: ABLATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
- TABLE 133 LATIN AMERICA: ABLATION TECHNOLOGY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 134 LATIN AMERICA: ABLATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
- TABLE 135 LATIN AMERICA: ABLATION TECHNOLOGY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
- TABLE 136 LATIN AMERICA: ABLATION TECHNOLOGY SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 137 LATIN AMERICA: RADIOFREQUENCY ABLATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 138 LATIN AMERICA: LASER/LIGHT ABLATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 139 LATIN AMERICA: ULTRASOUND ABLATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 140 LATIN AMERICA: ELECTRICAL ABLATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 141 LATIN AMERICA: ABLATION TECHNOLOGY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
- TABLE 142 LATIN AMERICA: ABLATION TECHNOLOGY MARKET, BY END USER, 2022–2029 (USD MILLION)
- TABLE 143 LATIN AMERICA: KEY MACROINDICATORS
- TABLE 144 BRAZIL: ABLATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
- TABLE 145 MEXICO: ABLATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
- TABLE 146 REST OF LATIN AMERICA: ABLATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
- TABLE 147 MIDDLE EAST & AFRICA: ABLATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
- TABLE 148 MIDDLE EAST & AFRICA: ABLATION TECHNOLOGY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
- TABLE 149 MIDDLE EAST & AFRICA: ABLATION TECHNOLOGY SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 150 MIDDLE EAST & AFRICA: RADIOFREQUENCY ABLATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 151 MIDDLE EAST & AFRICA: LASER/LIGHT ABLATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 152 MIDDLE EAST & AFRICA: ULTRASOUND ABLATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 153 MIDDLE EAST & AFRICA: ELECTRICAL ABLATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 154 MIDDLE EAST & AFRICA: ABLATION TECHNOLOGY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
- TABLE 155 MIDDLE EAST & AFRICA: ABLATION TECHNOLOGY MARKET, BY END USER, 2022–2029 (USD MILLION)
- TABLE 156 MIDDLE EAST & AFRICA: KEY MACROINDICATORS
- TABLE 157 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN ABLATION TECHNOLOGY MARKET
- TABLE 158 ABLATION TECHNOLOGY MARKET: DEGREE OF COMPETITION
- TABLE 159 ABLATION TECHNOLOGY MARKET: TECHNOLOGY FOOTPRINT
- TABLE 160 ABLATION TECHNOLOGY MARKET: PRODUCT FOOTPRINT
- TABLE 161 ABLATION TECHNOLOGY MARKET: APPLICATION FOOTPRINT
- TABLE 162 ABLATION TECHNOLOGY MARKET: END-USER FOOTPRINT
- TABLE 163 ABLATION TECHNOLOGY MARKET: REGION FOOTPRINT
- TABLE 164 ABLATION TECHNOLOGY MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS
- TABLE 165 ABLATION TECHNOLOGY MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS
- TABLE 166 ABLATION TECHNOLOGY MARKET: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021–JULY 2024
- TABLE 167 ABLATION TECHNOLOGY MARKET: DEALS, JANUARY 2021–JULY 2024
- TABLE 168 ABLATION TECHNOLOGY MARKET: EXPANSIONS, JANUARY 2021–JULY 2024
- TABLE 169 JOHNSON & JOHNSON: COMPANY OVERVIEW
- TABLE 170 JOHNSON & JOHNSON: PRODUCTS OFFERED
- TABLE 171 JOHNSON & JOHNSON: PRODUCT APPROVALS, JANUARY 2021−JULY 2024
- TABLE 172 JOHNSON & JOHNSON: DEALS, JANUARY 2021−JULY 2024
- TABLE 173 MEDTRONIC: COMPANY OVERVIEW
- TABLE 174 MEDTRONIC: PRODUCTS OFFERED
- TABLE 175 MEDTRONIC: PRODUCT APPROVALS, JANUARY 2021−JULY 2024
- TABLE 176 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW
- TABLE 177 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED
- TABLE 178 BOSTON SCIENTIFIC CORPORATION: PRODUCT APPROVALS, JANUARY 2021−JULY 2024
- TABLE 179 BOSTON SCIENTIFIC CORPORATION: DEALS, JANUARY 2021−JULY 2024
- TABLE 180 ABBOTT: COMPANY OVERVIEW
- TABLE 181 ABBOTT: PRODUCTS OFFERED
- TABLE 182 ABBOTT: PRODUCT APPROVALS, JANUARY 2021−JULY 2024
- TABLE 183 ABBOTT: DEALS, JANUARY 2021−JULY 2024
- TABLE 184 ATRICURE, INC.: COMPANY OVERVIEW
- TABLE 185 ATRICURE, INC.: PRODUCTS OFFERED
- TABLE 186 ATRICURE, INC.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021−JULY 2024
- TABLE 187 ANGIODYNAMICS: COMPANY OVERVIEW
- TABLE 188 ANGIODYNAMICS: PRODUCTS OFFERED
- TABLE 189 ANGIODYNAMICS: DEALS, JANUARY 2021−JULY 2024
- TABLE 190 CONMED CORPORATION: COMPANY OVERVIEW
- TABLE 191 CONMED CORPORATION: PRODUCTS OFFERED
- TABLE 192 OLYMPUS CORPORATION: COMPANY OVERVIEW
- TABLE 193 OLYMPUS CORPORATION: PRODUCTS OFFERED
- TABLE 194 OLYMPUS CORPORATION: PRODUCT LAUNCHES, JANUARY 2021−JULY 2024
- TABLE 195 OLYMPUS CORPORATION: DEALS, JANUARY 2021−JULY 2024
- TABLE 196 VARIAN MEDICAL SYSTEMS, INC.: COMPANY OVERVIEW
- TABLE 197 VARIAN MEDICAL SYSTEMS, INC.: PRODUCTS OFFERED
- TABLE 198 VARIAN MEDICAL SYSTEMS, INC.: PRODUCT LAUNCHES, JANUARY 2021−JULY 2024
- TABLE 199 VARIAN MEDICAL SYSTEMS, INC.: DEALS, JANUARY 2021−JULY 2024
- TABLE 200 SMITH+NEPHEW: COMPANY OVERVIEW
- TABLE 201 SMITH+NEPHEW: PRODUCTS OFFERED
- TABLE 202 SMITH+NEPHEW: EXPANSIONS, JANUARY 2021−JULY 2024
- TABLE 203 STRYKER: COMPANY OVERVIEW
- TABLE 204 STRYKER: PRODUCTS OFFERED
- TABLE 205 STRYKER: PRODUCT APPROVALS, JANUARY 2021−JULY 2024
- TABLE 206 STRYKER: EXPANSIONS, JANUARY 2021−JULY 2024
- TABLE 207 CYNOSURE LUTRONIC: COMPANY OVERVIEW
- TABLE 208 CYNOSURE LUTRONIC: PRODUCTS OFFERED
- TABLE 209 CYNOSURE LUTRONIC: DEALS, JANUARY 2021−JULY 2024
- TABLE 210 BIOVENTUS: COMPANY OVERVIEW
- TABLE 211 BIOVENTUS: PRODUCTS OFFERED
- TABLE 212 BIOVENTUS: DEALS, JANUARY 2021−JULY 2024
- TABLE 213 MERIT MEDICAL SYSTEMS: COMPANY OVERVIEW
- TABLE 214 MERIT MEDICAL SYSTEMS: PRODUCTS OFFERED
- TABLE 215 CANYON MEDICAL INC.: COMPANY OVERVIEW
- TABLE 216 CANYON MEDICAL INC.: PRODUCTS OFFERED
- TABLE 217 ARTHREX, INC.: COMPANY OVERVIEW
- TABLE 218 ICECURE MEDICAL: COMPANY OVERVIEW
- TABLE 219 MINIMAX MEDICAL HOLDING GROUP: COMPANY OVERVIEW
- TABLE 220 CARDIOFOCUS: COMPANY OVERVIEW
- TABLE 221 EDAP TMS: COMPANY OVERVIEW
- TABLE 222 MERMAID MEDICAL: COMPANY OVERVIEW
- TABLE 223 MONTERIS: COMPANY OVERVIEW
- TABLE 224 SONABLATE CORP.: COMPANY OVERVIEW
- TABLE 225 ECO MEDICAL: COMPANY OVERVIEW
- TABLE 226 SURGNOVA: COMPANY OVERVIEW
- FIGURE 1 ABLATION TECHNOLOGY MARKET: SEGMENTS CONSIDERED
- FIGURE 2 ABLATION TECHNOLOGY MARKET: YEARS CONSIDERED
- FIGURE 3 ABLATION TECHNOLOGY MARKET: RESEARCH DESIGN
- FIGURE 4 ABLATION TECHNOLOGY MARKET: KEY PRIMARY SOURCES
- FIGURE 5 ABLATION TECHNOLOGY MARKET: KEY PRIMARY INSIGHTS
- FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY- AND DEMAND-SIDE PARTICIPANTS
- FIGURE 7 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
- FIGURE 8 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
- FIGURE 9 ABLATION TECHNOLOGY MARKET: COMPANY REVENUE ESTIMATION APPROACH
- FIGURE 10 ABLATION TECHNOLOGY MARKET: CUSTOMER-BASED MARKET ESTIMATION
- FIGURE 11 CAGR PROJECTION: SUPPLY-SIDE ANALYSIS
- FIGURE 12 DATA TRIANGULATION METHODOLOGY
- FIGURE 13 ABLATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2024 VS. 2029 (USD MILLION)
- FIGURE 14 ABLATION TECHNOLOGY MARKET, BY PRODUCT, 2024 VS. 2029 (USD MILLION)
- FIGURE 15 ABLATION TECHNOLOGY MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
- FIGURE 16 ABLATION TECHNOLOGY MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
- FIGURE 17 ABLATION TECHNOLOGY MARKET: REGIONAL SNAPSHOT
- FIGURE 18 INCREASING DEMAND FOR MINIMALLY INVASIVE PROCEDURES TO DRIVE MARKET
- FIGURE 19 PULSED-FIELD ABLATION TO REGISTER HIGHEST CAGR IN NORTH AMERICAN MARKET DURING FORECAST PERIOD
- FIGURE 20 AMBULATORY SURGERY CENTERS TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
- FIGURE 21 CARDIOVASCULAR DISEASE TREATMENT TO ACCOUNT FOR LARGEST MARKET SHARE IN 2029
- FIGURE 22 INDIA TO WITNESS HIGHEST CAGR DURING STUDY PERIOD
- FIGURE 23 ABLATION TECHNOLOGY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
- FIGURE 24 ABLATION TECHNOLOGY MARKET: VALUE CHAIN ANALYSIS
- FIGURE 25 ABLATION TECHNOLOGY MARKET: SUPPLY CHAIN ANALYSIS
- FIGURE 26 ABLATION TECHNOLOGY MARKET: ECOSYSTEM ANALYSIS
- FIGURE 27 PREMARKET NOTIFICATION: 510(K) APPROVAL FOR MEDICAL DEVICES
- FIGURE 28 CANADA: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES
- FIGURE 29 EUROPE: CE APPROVAL PROCESS FOR MEDICAL DEVICES
- FIGURE 30 FUNDING AND NUMBER OF DEALS IN ABLATION TECHNOLOGY MARKET, 2018−2022 (USD MILLION)
- FIGURE 31 NUMBER OF INVESTOR DEALS IN ABLATION TECHNOLOGY MARKET, BY KEY PLAYER, 2018–2022 (UNIT)
- FIGURE 32 VALUE OF INVESTOR DEALS IN ABLATION TECHNOLOGY MARKET, BY KEY PLAYER, 2018–2022 (USD MILLION)
- FIGURE 33 AVERAGE SELLING PRICE TREND OF ABLATION SYSTEMS, BY TECHNOLOGY (2023)
- FIGURE 34 AVERAGE SELLING PRICE TREND OF ABLATION SYSTEMS, BY REGION (2023)
- FIGURE 35 TOP PATENT OWNERS/APPLICANTS IN ABLATION TECHNOLOGY MARKET (2013–2023)
- FIGURE 36 ABLATION TECHNOLOGY MARKET: PORTER’S FIVE FORCES ANALYSIS
- FIGURE 37 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR ABLATION TECHNOLOGY PRODUCTS
- FIGURE 38 KEY BUYING CRITERIA
- FIGURE 39 KEY BUYING CRITERIA FOR END USERS
- FIGURE 40 ABLATION TECHNOLOGY MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
- FIGURE 41 MARKET POTENTIAL OF AI/GENERATIVE AI ON ABLATION TECHNOLOGIES
- FIGURE 42 NORTH AMERICA: ABLATION TECHNOLOGY MARKET SNAPSHOT
- FIGURE 43 ASIA PACIFIC: ABLATION TECHNOLOGY MARKET SNAPSHOT
- FIGURE 44 REVENUE ANALYSIS OF KEY PLAYERS IN ABLATION TECHNOLOGY MARKET (2019−2023)
- FIGURE 45 MARKET SHARE ANALYSIS OF KEY PLAYERS IN ABLATION TECHNOLOGY MARKET (2023)
- FIGURE 46 ABLATION TECHNOLOGY MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
- FIGURE 47 ABLATION TECHNOLOGY MARKET: COMPANY FOOTPRINT
- FIGURE 48 ABLATION TECHNOLOGY MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
- FIGURE 49 EV/EBITDA OF KEY VENDORS
- FIGURE 50 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
- FIGURE 51 ABLATION TECHNOLOGY MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
- FIGURE 52 JOHNSON & JOHNSON: COMPANY SNAPSHOT (2023)
- FIGURE 53 MEDTRONIC: COMPANY SNAPSHOT (2023)
- FIGURE 54 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2023)
- FIGURE 55 ABBOTT: COMPANY SNAPSHOT (2023)
- FIGURE 56 ATRICURE, INC.: COMPANY SNAPSHOT (2023)
- FIGURE 57 ANGIODYNAMICS: COMPANY SNAPSHOT (2023)
- FIGURE 58 CONMED CORPORATION: COMPANY SNAPSHOT (2023)
- FIGURE 59 OLYMPUS CORPORATION: COMPANY SNAPSHOT (2023)
- FIGURE 60 VARIAN MEDICAL SYSTEMS, INC.: COMPANY SNAPSHOT (2023)
- FIGURE 61 SMITH+NEPHEW: COMPANY SNAPSHOT (2023)
- FIGURE 62 STRYKER: COMPANY SNAPSHOT (2023)
- FIGURE 63 BIOVENTUS: COMPANY SNAPSHOT (2023)
- FIGURE 64 MERIT MEDICAL SYSTEMS: COMPANY SNAPSHOT (2023)
This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, fundamental market dynamics, and key player strategies.
Secondary Research
The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B), white papers, annual reports, companies house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the ablation technology market. A database of the key industry leaders was also prepared using secondary research.
Primary Research
Primary research was conducted after acquiring extensive knowledge about the global ablation technology market scenario through secondary research. Primary interviews were conducted with market experts from both the demand-side (such as hospitals, research universities, academic institutions, and government institutions, among others) and supply-side respondents (such as presidents, CEOs, vice presidents, directors, general managers, heads of business units, and senior managers) across five major geographies, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East, and Africa. Approximately 30% of the primary interviews were conducted with stakeholders from the demand side, while those from the supply side accounted for the remaining 70%. Primary data for this report was collected through questionnaires, emails, and telephonic interviews.
A breakdown of the primary respondents is provided below:
To know about the assumptions considered for the study, download the pdf brochure
Market Estimation Methodology
A detailed market estimation approach was followed to estimate and validate the size of the global ablation technology market and other dependent submarkets.
- Key players in the global ablation technology market were identified through secondary research, and their global market shares were determined through primary and secondary research.
- The research methodology included the study of the annual and quarterly financial reports & regulatory filings of major market players as well as interviews with industry experts (such as CEOs, VPs, directors, and marketing executives) for detailed insights (both qualitative and quantitative trends) on the ablation technology market.
- All percentage shares, splits, and breakdowns for the global ablation technology market were determined by using secondary sources and verified through primary sources.
- All the key macro indicators affecting the revenue growth of the market segments and sub-segments have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the validated and verified quantitative & qualitative data.
- The gathered market data was consolidated and added to detailed inputs, analyzed, and presented in this report.
The above-mentioned data was consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in this report.
Data Triangulation:
After arriving at the overall size of the global ablation technology market through the above-mentioned methodology, this market was split into several segments and sub-segments. The data triangulation and market breakdown procedures were employed, wherever applicable, to complete the overall market engineering process and arrive at the exact market value data for the key segments and sub-segments. The extrapolated market data was triangulated by studying various macro indicators and regional trends from both the demand- and supply-side participants.
Report Objectives:
- To define, describe, and forecast the ablation technology market based on type, product, application, end user, and region
- To provide detailed information regarding the major factors influencing the growth of the global ablation technology market (such as drivers, restraints, challenges, opportunities, and regulatory landscape, among others)
- To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the global ablation technology market
- To analyze the opportunities in the global ablation technology market for stakeholders and provide details of the competitive landscape for market leaders
- To profile key global players and comprehensively analyze their market shares and core competencies
- To provide a five-year forecast for various market segments in terms of revenue with respect to five main regions, namely, North America (includes the US and Canada), Europe (includes Germany, the UK, France, Italy, and Spain), Asia Pacific (includes Japan, China, India, Australia, and South Korea), Latin America (includes Brazil and Mexico), and the Middle East & Africa
- To track and analyze competitive developments such as product launches; expansions, and mergers and acquisitions; and research and development activities in the ablation technology market
Available Customizations
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the global ablation technology market report:
Product analysis
- Product matrix, which gives a detailed comparison of the product portfolios of the top five companies
Company information
- Detailed analysis and profiling of additional market players (up to five)
Geographic analysis
- Further breakdown of the Rest of Europe ablation technology market into Belgium, Austria, Denmark, Greece, Poland, and Russia, among other countries
- Further breakdown of the Rest of Asia Pacific ablation technology market into New Zealand, Vietnam, Philippines, Singapore, Malaysia, Thailand, and Indonesia, among other countries
- Further breakdown of the Rest of Latin America ablation technology market into Argentina and Colombia, among other countries
Top players operating in Ablation systems Market
- Abbott Laboratories
- AngioDynamics Inc.
- AtriCure Inc.
- Biosense Webster Inc. (Johnson & Johnson)
- Boston Scientific Corporation
- CONMED Corporation
- Medtronic plc
- Olympus Corporation
- Smith & Nephew plc
- Varian Medical Systems Inc.
Niche growth drivers for Ablation systems Market
Growing demand for minimally invasive procedures: Ablation procedures are minimally invasive and have the potential to reduce recovery time and hospital stays. As a result, there is growing demand for ablation procedures, which is expected to drive the growth of the ablation systems market.
Increasing prevalence of chronic diseases: Ablation systems are used to treat various chronic diseases such as atrial fibrillation, cancer, and chronic pain. As the prevalence of these diseases continues to rise, the demand for ablation systems is also expected to increase.
Technological advancements in ablation systems: Advancements in ablation systems, such as the development of new ablation catheters, are expected to drive the growth of the ablation systems market. New technologies have the potential to improve the efficacy of ablation procedures and make them more accessible to patients.
Rising geriatric population: The aging population is at a higher risk of developing chronic diseases that require ablation procedures. As the geriatric population continues to grow, the demand for ablation systems is expected to increase.
Increasing investments in healthcare infrastructure: Governments and private organizations are investing in healthcare infrastructure, including the development of new hospitals and clinics. This is expected to increase the availability of ablation systems and drive the growth of the market.
Rising demand for cosmetic procedures: Ablation systems are also used in cosmetic procedures such as laser hair removal and skin rejuvenation. As the demand for cosmetic procedures continues to rise, the demand for ablation systems is also expected to increase.
Future Ablation systems Market trends
Increased use of robotic-assisted ablation: Robotic-assisted ablation allows for greater precision and control during procedures, which may improve patient outcomes. As a result, the use of robotic-assisted ablation is expected to increase in the future.
Expansion into emerging markets: As healthcare infrastructure improves in emerging markets, there is expected to be increased demand for ablation systems. As a result, companies may expand their operations into these markets to take advantage of the growing demand.
Development of new ablation techniques: There is ongoing research into new ablation techniques that may be more effective and have fewer side effects than current techniques. As these new techniques are developed and approved, they may drive the growth of the ablation systems market.
Growing demand for image-guided ablation: Image-guided ablation allows for greater accuracy during procedures, which may improve patient outcomes. As a result, there is expected to be increased demand for image-guided ablation in the future.
Adoption of disposable ablation devices: Disposable ablation devices are more convenient and may reduce the risk of infection during procedures. As a result, there is expected to be increased adoption of disposable ablation devices in the future.
Increasing focus on outpatient procedures: Ablation procedures can be performed on an outpatient basis, which may reduce healthcare costs and improve patient satisfaction. As a result, there is expected to be an increasing focus on performing ablation procedures in outpatient settings.
Future hypothetic growth opportunity for Ablation systems Market
One potential future growth opportunity for the Ablation Systems Market is the development of new indications for ablation therapy. Ablation therapy is currently used to treat a variety of conditions, including cancer, atrial fibrillation, and chronic pain. However, there may be new indications for ablation therapy that have not yet been explored.
For example, there is ongoing research into the use of ablation therapy to treat psychiatric disorders such as depression and obsessive-compulsive disorder. If these new indications are proven effective and approved by regulatory agencies, it could drive significant growth in the ablation systems market.
Another potential growth opportunity is the development of new ablation technologies that are more effective and have fewer side effects than current technologies. As research in this area continues, new ablation technologies may be developed that can treat a wider range of conditions and improve patient outcomes.
Finally, the continued expansion of healthcare infrastructure in emerging markets could also drive growth in the ablation systems market. As access to healthcare improves in these markets, there is likely to be increased demand for ablation therapy, which could create new growth opportunities for companies operating in the market.
Niche threats/restraints for Ablation systems Market in enterprise
High cost: Ablation systems can be expensive, and this may limit their adoption in certain markets. Hospitals and healthcare providers may be hesitant to invest in expensive equipment, especially if they are unsure about the long-term return on investment.
Competition from alternative therapies: Ablation therapy competes with other therapies, including surgery and radiation therapy. The availability of alternative therapies may limit the adoption of ablation systems, particularly in cases where these alternative therapies are proven effective.
Regulatory hurdles: The regulatory environment for ablation systems is complex and constantly evolving. Companies operating in the market may face challenges obtaining regulatory approval for new products or expanding into new markets.
Limited reimbursement: The availability of reimbursement for ablation therapy varies by region and may limit the adoption of these systems. In some markets, reimbursement for ablation therapy may be limited, which could impact the willingness of hospitals and healthcare providers to invest in these systems.
Limited clinical evidence: Despite the growing use of ablation therapy, there is still limited clinical evidence supporting its effectiveness for certain conditions. The lack of robust clinical evidence may limit the adoption of these systems, particularly in cases where other therapies have established clinical evidence.
Growth opportunities and latent adjacency in Ablation Technology Market
Looking information on ablation technology market growth to invest
Detailed US geo analysis of Ablation Technology Market - Forecast 2022 to 2030.